Dntox
human cell-based test system that maps important processes of human brain development and thus the allows for non-animal testing of chemicals
Dntox has raised €1.5M across 1 funding round from 5 investors, most recently a round in Jun 2023. Based in Dusseldorf, Germany; active in Healthtech. Data as of 28 Oct 2026.
Dusseldorf, Germanydntox.de ↗
Total raised
€1.5M
€1,500,000
Funding rounds
1
Investors
5
distinct backers
Active since
2023-06
latest 2023-06
Funding by year
EUR raised per yearDntox — funding by year — interactive chart.
Data table
| Dntox — funding by year | |
|---|---|
| 2023 | €1.5M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-06-14 | Other | €1.5M | AQAL Capital,Barbara Korte-Sturm,Bool Capital,High-Tech Gründerfonds (HTGF),Nikolaus Sturm | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData